1. Home
  2. TTD vs ILMN Comparison

TTD vs ILMN Comparison

Compare TTD & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Trade Desk Inc.

TTD

The Trade Desk Inc.

HOLD

Current Price

$35.36

Market Cap

18.2B

Sector

Technology

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$142.33

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTD
ILMN
Founded
2009
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2B
20.5B
IPO Year
2016
2000

Fundamental Metrics

Financial Performance
Metric
TTD
ILMN
Price
$35.36
$142.33
Analyst Decision
Buy
Hold
Analyst Count
34
16
Target Price
$75.42
$121.00
AVG Volume (30 Days)
13.0M
1.7M
Earning Date
02-11-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
42.00
N/A
EPS
0.88
4.46
Revenue
$2,790,505,000.00
$4,288,000,000.00
Revenue This Year
$19.44
N/A
Revenue Next Year
$16.13
$2.38
P/E Ratio
$41.15
$32.57
Revenue Growth
20.82
N/A
52 Week Low
$35.65
$68.70
52 Week High
$126.20
$151.34

Technical Indicators

Market Signals
Indicator
TTD
ILMN
Relative Strength Index (RSI) 32.24 55.72
Support Level $36.25 $140.19
Resistance Level $37.77 $151.00
Average True Range (ATR) 1.22 4.91
MACD -0.09 -0.22
Stochastic Oscillator 1.41 55.38

Price Performance

Historical Comparison
TTD
ILMN

About TTD The Trade Desk Inc.

The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: